![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 19, 13118-13126, May 7, 1999
-Irradiation and
Altered Cell Cycle Regulation by Insulin-like Growth Factor II
Overexpression
,
,
,
,
,
From the High levels of insulin-like growth factor II
(IGFII) mRNA expression are detected in many human tumors of
different origins including rhabdomyosarcoma, a tumor of skeletal
muscle origin. To investigate the role of IGFII in tumorigenesis, we
have compared the mouse myoblast cell line C2C12-2.7, which was stably
transfected with human IGFII cDNA and expressed high and constant
amounts of IGFII, to a control cell line C2C12-1.1. A rhabdomyosarcoma cell line, RH30, which expresses high levels of IGFII and contains mutated p53, was also used in these studies. IGFII overexpression in
mouse myoblast C2C12 cells causes a reduced cycling time and higher
growth rate. After
Molecular Oncology Section,
§ Medical Breast Cancer Section, ¶ Cell Signaling and
Oncogenesis Section,
Liver Diseases Section,
-irradiation treatment, C2C12-1.1 cells were
arrested mainly in G0/G1 phase. However,
C2C12-2.7 and RH30 cells went through a very short G1 phase
and then were arrested in an extended G2/M phase. To verify
further the effect of IGFII on the cell cycle, we developed a Chinese
hamster ovary (CHO) cell line with tetracycline-controlled IGFII
expression. We found that CHO cells with high expression of IGFII have
a shortened cycling time and a diminished G1 checkpoint
after treatment with methylmethane sulfonate (MMS), a DNA base-damaging
agent, when compared with CHO cells with very low IGFII expression. It
was also found that IGFII overexpression in C2C12 cells was associated with increases in cyclin D1, p21, and p53 protein levels, as well as
mitogen-activated protein kinase activity. These studies suggest that
IGFII overexpression shortens cell cycling time and diminishes the
G1 checkpoint after DNA damage despite an intact p53/p21
induction. In addition, IGFII overexpression is also associated with
multiple changes in the levels and activities of cell cycle regulatory components following
-irradiation. Taken together, these changes may
contribute to the high growth rate and genetic alterations that occur
during tumorigenesis.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
This article has been cited by other articles:
![]() |
J. Jaboin, J. Wild, H. Hamidi, C. Khanna, C. J. Kim, R. Robey, S. E. Bates, and C. J. Thiele MS-27-275, an Inhibitor of Histone Deacetylase, Has Marked in Vitro and in Vivo Antitumor Activity against Pediatric Solid Tumors Cancer Res., November 1, 2002; 62(21): 6108 - 6115. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler The Somatomedin Hypothesis: 2001 Endocr. Rev., February 1, 2001; 22(1): 53 - 74. [Abstract] [Full Text] |
||||
![]() |
T. Caspary, M. A. Cleary, E. J. Perlman, P. Zhang, S. J. Elledge, and S. M. Tilghman Oppositely imprinted genes p57Kip2 and Igf2 interact in a mouse model for Beckwith-Wiedemann syndrome Genes & Dev., December 1, 1999; 13(23): 3115 - 3124. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |